Article info
PDFPostScript
Correspondence
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
- Correspondence to Dr Umair Tahir Khan, Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GE, UK; ukhan{at}liv.ac.uk
Citation
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
Publication history
- Received September 17, 2020
- Revised December 2, 2020
- Accepted December 3, 2020
- First published December 30, 2020.
Online issue publication
November 19, 2021
Article Versions
- Previous version (30 December 2020).
- Previous version (28 September 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.